How many insider trades does FilingIQ track for OABI?

FilingIQ tracks 206 Form 4 insider transactions for OABI (OmniAb, Inc.), covering filings from Nov 1, 2022 onwards. 37 of those were filed in the last 90 days.

Are OABI insiders net buyers or net sellers?

Across the full Form 4 history for OABI, 23 transactions (11%) were open-market purchases and 33 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OABI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OABI in?

OmniAb, Inc. (OABI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $246.16M.

OABI insider trading

NasdaqGM Healthcare

OmniAb, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

206

Last 90 days

Buys / sells

11% / 16%

Market cap

$246.16M

About OmniAb, Inc.

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

Company website: www.omniab.com

OABI insider activity at a glance

FilingIQ has scored 206 insider transactions for OABI since Nov 1, 2022. The most recent filing in our index is dated Apr 21, 2026.

Across the full history, 23 open-market purchases and 33 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OABI insider trades is 58.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OABI trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for OABI?: FilingIQ tracks 206 Form 4 insider transactions for OABI (OmniAb, Inc.), covering filings from Nov 1, 2022 onwards. 37 of those were filed in the last 90 days.
Are OABI insiders net buyers or net sellers?: Across the full Form 4 history for OABI, 23 transactions (11%) were open-market purchases and 33 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OABI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OABI in?: OmniAb, Inc. (OABI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $246.16M.

Methodology & sources

Every OABI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.